EGFR and small cell lung carcinoma: Furthermore, transformed SCLC cases were enriched with various molecular pathway alterations, including MAPK, Jak-STAT, ERBB, FGFR, mechanistic targeting of rapamycin kinase signaling, and PI3K-AKT-mTOR pathways [19].